Product Information
EXEMESTANE 25 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6119 per EA under NDC 59651051630. Its NADAC has been published 183 times since Dec 28, 2022.
Strength
25 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651051630
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EXEMESTANEApproval Type
Generic (ANDA)
FDA Application
ANDA216454On Market Since
5/20/2022
Pharmacological Classes
Price Statistics
The NADAC for EXEMESTANE 25 MG TABLET has been published 183 times since Dec 28, 2022, and over the history we have for it it has declined 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6119 per EA |
|---|---|
| All-time high | $1.0787 (Dec 13, 2023) |
| All-time low | $0.5602 (Jul 17, 2024) |
| 52-week high | $0.8721 |
| 52-week low | $0.5751 |
| Median price | $0.7987 |
| Average price | $0.7900 |
| Largest weekly change | +39.9% (Jan 18, 2023) |
| Weeks tracked | 183 |
| Tracking since | Dec 28, 2022 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EXEMESTANE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EXEMESTANE 25 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6119 per EA (NDC 59651051630), effective Jun 24, 2026.
How has the price of EXEMESTANE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for EXEMESTANE 25 MG TABLET has declined 14.2%. It has been tracked across 183 weekly CMS publications since Dec 28, 2022.
What are the highest and lowest recorded NADAC prices for EXEMESTANE 25 MG TABLET?
Since Dec 28, 2022, the NADAC for EXEMESTANE 25 MG TABLET has ranged from a low of $0.5602 (Jul 17, 2024) to a high of $1.0787 (Dec 13, 2023), with a median of $0.7987 per EA.
Are there cheaper alternatives to EXEMESTANE 25 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as EXEMESTANE 25 MG TABLET, but none are currently priced below it.
Who manufactures EXEMESTANE 25 MG TABLET?
EXEMESTANE 25 MG TABLET (NDC 59651051630) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification